Latest Shareholder Approval News

FMR Resources has secured a conditional right to earn a 60% stake in the promising Llahuin copper-gold-molybdenite project in Chile, backed by a $2.2 million capital raise and a new Managing Director appointment.

Australian Strategic Materials has initiated a $3 million underwritten Share Purchase Plan to accelerate its US metallisation expansion and boost capabilities at its Korean Metals Plant, signaling a strategic push amid shifting global supply dynamics.

Kip McGrath Education Centres has appointed Melinda Smith as CEO and Managing Director, signaling a new leadership era ahead of its 50th anniversary. Smith’s extensive experience in education and government sectors positions her to lead the company’s growth ambitions from the second half of 2025.

Butn Limited has raised $20 million through a $10 million equity placement and a $10 million credit facility, positioning the fintech for expanded growth in SME funding.

West Wits Mining has raised approximately A$14.36 million through a share placement to fund production at its Qala Shallows gold project and increase its ownership in the Witwatersrand Basin Project to 74%.

Hazer Group has raised A$8 million through a share placement and launched a A$2 million Share Purchase Plan to accelerate its clean hydrogen and graphite technology commercialisation.

PointsBet’s board has unanimously dismissed Betr Entertainment’s acquisition proposal, reaffirming that MIXI Australia’s $1.20 per share cash offer remains the superior path forward for shareholders.

PointsBet Holdings has formalised a conditional takeover bid deed with MIXI at $1.20 per share, activating if shareholders reject the current scheme of arrangement. The deal hinges on key regulatory approvals and a minimum 50.1% acceptance threshold.

Harvest Technology Group’s CEO, Ilario Faenza, has stepped in with a $500,000 unsecured loan to support the company’s working capital, highlighting ongoing liquidity management efforts.

Solstice Minerals secures a $2.13 million strategic placement from Paradice Investment Management, making Paradice its largest shareholder and fueling exploration at key Western Australian projects.

Mayne Pharma rejects Cosette Pharmaceuticals’ claims of valid termination of their scheme deal, setting the stage for a September court showdown while urging shareholders to back the scheme in June.

Santos Limited has received a compelling non-binding proposal from the XRG Consortium to acquire the company at a significant premium, prompting the board to engage in due diligence and negotiations. This move could reshape the Australian energy landscape if finalized.